Updated on 2024/09/25

写真a

 
OGAWA, Yasushi
 
Organization
Nagoya University Hospital Lecturer
Graduate School
Graduate School of Medicine
Title
Lecturer

Degree 1

  1. 博士(医学) ( 2004.11   名古屋大学 ) 

Research Interests 4

  1. chemical biology

  2. epigenetics

  3. inflammatory keratosis

  4. dermatology

Research Areas 4

  1. Others / Others  / Dermatology

  2. Life Science / Connective tissue disease and allergy  / リアルワールドデータ

  3. Humanities & Social Sciences / Sociology of science, history of science and technology  / 書誌計量学

  4. Life Science / Dermatology

Current Research Project and SDGs 4

  1. 免疫アレルギー疾患対策に関する研究基盤及び評価基盤の構築」

  2. レセプト情報を用いた免疫アレルギー疾患の臨床分析

  3. 研究者多様性が研究開発イノベーションにもたらす効果の書誌計量学的分析

  4. アトピー性皮膚炎をモデルとした次世代リバーストランスレーション研究基盤構築に向けた研究

Research History 5

  1. Nagoya University   Department of Advanced Medicine, Nagoya University Hospital   Lecturer

    2020.5

      More details

    Country:Japan

  2. Japan Agency for Medical Research and Development   Department of Research Promotion, Division of Rare / Intractable Disease Research   Deputy Manager

    2018.4 - 2020.4

      More details

    Country:Japan

  3. Laboratory of Gene Expression, Graduate School of Biomedical Science, Tokyo Medical and Dental UniversityResearch Assistant Professor

    2007.1 - 2010.3

      More details

    Country:Japan

  4. University of Texas Southwestern Medical Center at DallasDepartment of PathologyPostdoctoral fellow

    2005.4 - 2007.1

  5. University of Texas Southwestern Medical Center at DallasDepartment of DermatologyPostdoctoral Fellow

    2004.4 - 2005.3

Education 3

  1. Nagoya University   Graduate School of Medicine   Dermatology

    2000.4 - 2004.3

      More details

    Country: Japan

  2. Nagoya University   Faculty of Medicine

    - 1998.3

      More details

    Country: Japan

  3. Nagoya University   School of Medicine

    1992.4 - 1998.3

      More details

    Country: Japan

Professional Memberships 4

  1. 加齢皮膚医学研究会

  2. The Japanese Pharmacological Society

  3. Japanese Dermatological Association

  4. The Japanese Society for Investigative Dermatology

Committee Memberships 1

  1. 日本皮膚科学会   医療戦略委員  

    2018.6   

Awards 3

  1. 第1回 高木賞

    2017   公益財団法人マルホ・高木皮膚科学振興財団  

  2. 第16回ガルデルマ賞

    2015  

  3. 加齢皮膚医学研究基金(ロート賞)

    2011   加齢皮膚医学研究会  

 

Papers 52

  1. The impact of COVID-19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database

    Yasutsugu Akasaki, Takenori Inomata, Masao Iwagami, Jaemyoung Sung, Ken Nagino, Takeya Adachi, Hideaki Morita, Mayumi Tamari, Keigo Kainuma, Keiko Kan-o, Hiroaki Ogata, Masafumi Sakashita, Masaki Futamura, Yosuke Kurashima, Saeko Nakajima, Katsunori Masaki, Yasushi Ogawa, Sakura Sato, Akihiro Miyagawa, Akie Midorikawa-Inomata, Keiichi Fujimoto, Yuichi Okumura, Kenta Fujio, Tianxiang Huang, Kunihiko Hirosawa, Yuki Morooka, Akira Murakami, Shintaro Nakao

    Clinical and Translational Allergy   Vol. 14 ( 9 )   2024.9

     More details

    Publishing type:Research paper (scientific journal)  

    Background: Hay fever (HF) presents with various symptoms, including allergic conjunctivitis and rhinitis, and requires cross-organ treatment. This study assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on HF treatment trends. Methods: This retrospective cohort study utilized data from the JMDC database collected between January 2018 and May 2021. Patients with HF were identified based on the relevant International Classification of Diseases 10th Revision diagnosis codes and the prescription of HF-related medications. The treatment approaches were compared during the cedar and cypress pollen allergy season (January to May in Japan) before and during the COVID-19 pandemic (2018 and 2019, and 2020 and 2021, respectively). Results: This study included 2,598,178 patients with HF. The numbers of prescribed HF-related claims in 2018, 2019, 2020, and 2021 were 3,332,854, 3,534,198, 2,774,380, and 2,786,681 times, respectively. Oral second-generation antihistamine prescriptions decreased by >10% from 2019 to 2020, with a <10% change in the subsequent year. Anti-allergic eye drop prescriptions also decreased by >10% from 2019 to 2020 but increased by >10% from 2020 to 2021. Compared with 2018, 2019, and 2020, the number of claims in the rhinitis symptoms dominant group was significantly decreased in 2021 (p < 0.001, all). In contrast, the number of claims in the eye symptoms dominant group and the rhinitis and eye symptoms dominant group increased in 2021 compared with that in 2018, 2019, and 2020 (p < 0.001, all). Conclusion: Changes in HF treatment and related outcomes could be attributed to lifestyle modifications resulting from the COVID-19 pandemic. Measures, such as limiting outdoor activities and adopting mask-wearing practices may have influenced HF symptoms, preventive behaviors, and the overall approach to treating HF.

    DOI: 10.1002/clt2.12394

    Scopus

  2. [RECURRENT AND VIRTUAL EDUCATION FOR ALL DISCIPLINES AND OCCUPATIONS IN THE ALLERGY REALM : A SURVEY OF THE PARTICIPANTS FROM THE INITIATIVE 'OUTREACH LECTURES' TO CREATE EDUCATIONAL OPPORTUNITIES] Reviewed

      Vol. 73 ( 4 ) page: 329 - 339   2024.6

     More details

  3. Updated mutational spectrum and genotype–phenotype correlations in ichthyosis patients with ABCA12 pathogenic variants

    Tatsuhiro Noda, Takuya Takeichi, Kana Tanahashi, Yasushi Ogawa, So Takeuchi, Takenori Yoshikawa, Erika Toriyama, Miwa Ashida, Sumihisa Imakado, Hitoshi Tsuchihashi, Takashi Okamoto, Yusuke Okuno, Tomoo Ogi, Kazumitsu Sugiura, Akiharu Kubo, Yoshinao Muro, Yasushi Suga, Akemi Ishida-Yamamoto, Masashi Akiyama

    Experimental Dermatology   Vol. 33 ( 4 )   2024.4

     More details

    Publishing type:Research paper (scientific journal)  

    Autosomal recessive congenital ichthyoses (ARCI) is a genetically heterogeneous condition that can be caused by pathogenic variants in at least 12 genes, including ABCA12. ARCI mainly consists of congenital ichthyosiform erythroderma (CIE), lamellar ichthyosis (LI) and harlequin ichthyosis (HI). The objective was to determine previously unreported pathogenic variants in ABCA12 and to update genotype–phenotype correlations for patients with pathogenic ABCA12 variants. Pathogenic variants in ABCA12 were detected using Sanger sequencing or a combination of Sanger sequencing and whole-exome sequencing. To verify the pathogenicity of a previously unreported large deletion and intron variant, cDNA analysis was performed using total RNA extracted from hair roots. Genetic analyses were performed on the patients with CIE, LI, HI and non-congenital ichthyosis with unusual phenotypes (NIUP), and 11 previously unreported ABCA12 variants were identified. Sequencing of cDNA confirmed the aberrant splicing of the variant ABCA12 in the patients with the previously unreported large deletion and intron variant. Our findings expand the phenotype spectrum of ichthyosis patients with ABCA12 pathogenic variants. The present missense variants in ABCA12 are considered to be heterogenous in pathogenicity, and they lead to varying disease severities in patients with ARCI and non-congenital ichthyosis with unusual phenotypes (NIUP).

    DOI: 10.1111/exd.15072

    Scopus

    PubMed

  4. [STATE-OF-THE-ART OF GLOBAL START-UP INVESTMENT FOR ALLERGY AND IMMUNOLOGY 2022].

    Takeya Adachi, Motoshi Hayano, Yasunori Ito, Takenori Inomata, Yasushi Ogawa, Keigo Kainuma, Keiko Kan-O, Yosuke Kurashima, Yu Kuwabara, Masafumi Sakashita, Sakura Sato, Yasuhiro Tomita, Saeko Nakajima, Masaki Futamura, Katsunori Masaki, Mayumi Tamari, Motohiro Ebisawa, Hideaki Morita

    Arerugi = [Allergy]   Vol. 73 ( 3 ) page: 268 - 278   2024

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    BACKGROUND: In 2022, the "New Capitalism Grand Design and Implementation Plan" was adopted in Japan, emphasizing the promotion and environmental development of startups. Given this context, an investigation into the startup and investment landscape in the allergy sector, both domestically and internationally, becomes imperative. METHODS: We analyzed 156 allergy-related startups from Japan, the US, and Europe from 2010 to 2021. Data on corporate information and investment trends were extracted from databases and VC websites. RESULTS: The total investment reached approximately 7.2 billion USD, with a ratio of 20:6:1 for the US, Europe, and Japan, respectively. The US showed a decline post its peak from 2016-2018, while Europe and Japan experienced growth. Notably, the US primarily invested in biopharmaceuticals for atopic dermatitis and food allergies, Europe in asthma-related apps, and Japan in healthcare apps and cross-border startups. DISCUSSION AND CONCLUSION: While Japan's investment environment in the allergy sector remains in its nascent stages and has room for development, the US and Europe are evidently ahead. Considering the rise of startups and funding limitations in Japan, external funding from regions like the US becomes a potential avenue. These findings are anticipated to contribute to the strategic activation of startups in allergy research and development.

    DOI: 10.15036/arerugi.73.268

    Scopus

    PubMed

  5. Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study Reviewed

    Yasutsugu Akasaki, Masao Iwagami, Jaemyoung Sung, Ken Nagino, Takeya Adachi, Hideaki Morita, Mayumi Tamari, Keigo Kainuma, Keiko Kan‐o, Hiroaki Ogata, Masafumi Sakashita, Masaki Futamura, Yosuke Kurashima, Saeko Nakajima, Katsunori Masaki, Yasushi Ogawa, Sakura Sato, Akihiro Miyagawa, Akie Midorikawa‐Inomata, Keiichi Fujimoto, Yuichi Okumura, Kenta Fujio, Tianxiang Huang, Kunihiko Hirosawa, Yuki Morooka, Shintaro Nakao, Akira Murakami, Hiroyuki Kobayashi, Takenori Inomata

    Allergy     2023.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/all.15947

  6. A case of advanced diffuse large B-cell lymphoma diagnosed from widespread superficial mycosis of the skin Invited Reviewed

    Yuika Suzuki, Chiaki Murase, Yoko Ushijima, Yuriko Hanai, Yasushi Ogawa, Takanori Toyama, Masashi Akiyama

    Journal of the European Academy of Dermatology and Venereology : JEADV     2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jdv.18937

  7. Research impact analysis of international funding agencies in the realm of allergy and immunology Reviewed

    Takeya Adachi, Yasushi Ogawa, Tamami Fukushi, Kei Ito, Amane Koizumi, Masashi Shirabe, Masako Toriya, Jun Hirako, Takenori Inomata, Katsunori Masaki, Ryohei Sasano, Sakura Sato, Keigo Kainuma, Masaki Futamura, Keiko Kan-O , Yosuke Kurashima, Saeko Nakajima, Masafumi Sakashita, Hideaki Morita, Aikichi Iwamoto, Sankei Nishima, Mayumi Tamari, Hajime Iizuka

    Allergy     2022.5

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.1111/all.15249

  8. Evaluation of adrenaline auto-injector prescription profiles: A population-based, retrospective cohort study within the National Insurance Claims Database of Japan Reviewed

    Sakura Sato, Keigo Kainuma, Tatsuya Noda, Motohiro Ebisawa, Masaki Futamura, Tomoaki Imamura, Akihiro Miyagawa, Saeko Nakajima, Yasushi Ogawa, Takenori Inomata, Keiko Kan-O, Yosuke Kurashima, Katsunori Masaki, Tomoya Myojin, Yuichi Nishioka, Masafumi Sakashita, Mayumi Tamari, Hideaki Morita, Takeya Adachi

        2022

     More details

    Language:English  

    DOI: 10.1016/j.alit.2022.02.002

  9. More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations Reviewed

    Lilly, E., Bunick, C.G., Maley, A.M., Zhang, S., Spraker, M.K., Theos, A.J., Vivar, K.L., Seminario-Vidal, L., Bennett, A.E., Sidbury, R., Ogawa, Y., Akiyama, M., Binder, B., Hadj-Rabia, S., Morotti, R.A., Glusac, E.J., Choate, K.A., Richard, G., Milstone, L.M.

    Journal of the American Academy of Dermatology   Vol. 80 ( 3 ) page: 617 - 625   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jaad.2018.09.042

    Scopus

  10. Survey on patients with undiagnosed diseases in Japan: Potential patient numbers benefiting from Japan's initiative on rare and undiagnosed diseases (IRUD) Reviewed

    Adachi, T., Imanishi, N., Ogawa, Y., Furusawa, Y., Izumida, Y., Izumi, Y., Suematsu, M.

    Orphanet Journal of Rare Diseases   Vol. 13 ( 1 ) page: 208   2018

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13023-018-0943-y

    Scopus

    PubMed

  11. Pigmented macules in Waardenburg syndrome type 2 due to KITLG mutation Reviewed

    Ogawa, Y., Kono, M., Akiyama, M.

    Pigment Cell and Melanoma Research   Vol. 30 ( 5 ) page: 501 - 504   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcmr.12597

    Web of Science

    Scopus

    PubMed

  12. Image Gallery: Unilaterally dominant acrokeratoelastoidosis (punctate palmoplantar keratoderma type 3) Reviewed

    Taki, T., Ogawa, Y., Sakakibara, A., Kono, M., Akiyama, M.

    British Journal of Dermatology   Vol. 177 ( 4 ) page: E157 - E157   2017

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/bjd.15817

    Web of Science

    Scopus

  13. Epstein-barr virus-associated natural killer/T-cell lymphoma in a patient receiving therapy with anti-tumour necrosis factor and thiopurine Reviewed

    Murase, C., Ogawa, Y., Yamamoto, A., Iriyama, C., Akiyama, M.

    Acta Dermato-Venereologica   Vol. 97 ( 2 ) page: 273 - 274   2017

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.2340/00015555-2529

    Web of Science

    Scopus

    PubMed

  14. Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia Reviewed

    Takeichi, T., Torrelo, A., Lee, J.Y.W., Ohno, Y., Lozano, M.L., Kihara, A., Liu, L., Yasuda, Y., Ishikawa, J., Murase, T., Rodrigo, A.B., Fernández-Crehuet, P., Toi, Y., Mellerio, J., Rivera, J., Vicente, V., Kelsell, D.P., Nishimura, Y., Okuno, Y., Kojima, D., Ogawa, Y., Sugiura, K., Simpson, M.A., McLean, W.H.I., Akiyama, M., McGrath, J.A.

    Journal of Investigative Dermatology   Vol. 137 ( 11 ) page: 2344 - 2353   2017

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jid.2017.06.028

    Web of Science

    Scopus

    PubMed

  15. 抗PM/Scl抗体陽性皮膚筋炎の3例

    滝 奉樹, 室 慶直, 小川 靖, 杉浦 一充, 秋山 真志

    日本皮膚科学会雑誌   Vol. 126 ( 1 ) page: 33 - 33   2016.1

     More details

    Language:Japanese   Publisher:(公社)日本皮膚科学会  

  16. IgE-independent pathophysiology of severe atopic dermatitis demonstrated in an IgE-deficient patient Reviewed

    Ogawa, Y., Kono, M., Tsujikawa, M., Tsujiuchi, H., Akiyama, M.

    Journal of Dermatological Science   Vol. 82 ( 2 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jdermsci.2016.01.008

    Scopus

  17. Unilateral generalized linear porokeratosis with nail dystrophy Reviewed

    Kono, M., Yokoyama, N., Ogawa, Y., Takama, H., Sugiura, K., Akiyama, M.

    Journal of Dermatology   Vol. 43 ( 3 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/1346-8138.13204

    Scopus

  18. Non-infectious panniculitis during hydroxyurea therapy in a patient with myeloproliferative disease Reviewed

    Ogawa, Y., Akiyama, M.

    Acta Dermato-Venereologica   Vol. 96 ( 4 )   2016

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.2340/00015555-2292

    Scopus

  19. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma. Reviewed

    Muro Y, Hosono Y, Sugiura K, Ogawa Y, Mimori T, Akiyama M.

    Arthritis Res Ther.   Vol. 17 ( 1 ) page: 57   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13075-015-0573-x.

  20. Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis Reviewed

    Masaki, S., Kii, I., Sumida, Y., Kato-Sumida, T., Ogawa, Y., Ito, N., Nakamura, M., Sonamoto, R., Kataoka, N., Hosoya, T., Hagiwara, M.

    Bioorganic and Medicinal Chemistry   Vol. 23 ( 15 ) page: 4434 - 4441   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PERGAMON-ELSEVIER SCIENCE LTD  

    Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) has been demonstrated in several pathological conditions, including Alzheimer's disease and cancer progression. It has been recently reported that a gain of function-mutation in the human DYRK1B gene exacerbates metabolic syndrome by enhancing obesity. In the previous study, we developed an inhibitor of DYRK family kinases (INDY) and demonstrated that INDY suppresses the pathological phenotypes induced by overexpression of DYRK1A or DYRK1B in cellular and animal models. In this study, we designed and synthesized a novel inhibitor of DYRK family kinases based on the crystal structure of the DYRK1A/INDY complex by replacing the phenol group of INDY with dibenzofuran to produce a derivative, named BINDY. This compound exhibited potent and selective inhibitory activity toward DYRK family kinases in an in vitro assay. Furthermore, treatment of 3T3-L1 pre-adipocytes with BINDY hampered adipogenesis by suppressing gene expression of the critical transcription factors PPARc and C/EBPa. This study indicates the possibility of BINDY as a potential drug for metabolic syndrome. (C) 2015 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2015.06.018

    Web of Science

    Scopus

  21. A Palindromic Motif in the -2084 to -2078 Upstream Region is Essential for ABCA12 Promoter Function in Cultured Human Keratinocytes Reviewed

    Yoshitaka Shimizu, Yasushi Ogawa, Kazumitsu Sugiura, Jun-ichi Takeda, Kaori Sakai-Sawada, Teruki Yanagi, Atsushi Kon, Daisuke Sawamura, Hiroshi Shimizu, Masashi Akiyama

    Scientific Reports   Vol. 4   page: 6737   2014.10

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  22. A palindromic motif in the -2084 to -2078 upstream region is essential for ABCA12 promoter function in cultured human keratinocytes Reviewed

    Shimizu, Y., Ogawa, Y., Sugiura, K., Takeda, J.-I., Sakai-Sawada, K., Yanagi, T., Kon, A., Sawamura, D., Shimizu, H., Akiyama, M.

    Scientific Reports   Vol. 4   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/srep06737

    Scopus

  23. Revertant Mutation Releases Confined Lethal Mutation, Opening Pandora's Box: A Novel Genetic Pathogenesis Reviewed

    Ogawa, Y., Takeichi, T., Kono, M., Hamajima, N., Yamamoto, T., Sugiura, K., Akiyama, M.

    PLoS Genetics   Vol. 10 ( 5 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pgen.1004276

    Scopus

  24. Nuclear envelope localization of Ran-binding protein 2 and Ran-GTPase-activating protein 1 in psoriatic epidermal keratinocytes Reviewed

    Yasuda, K., Sugiura, K., Takeichi, T., Ogawa, Y., Muro, Y., Akiyama, M.

    Experimental Dermatology   Vol. 23 ( 2 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/exd.12324

    Scopus

  25. High survival rate of harlequin ichthyosis in Japan Reviewed

    Shibata, A., Ogawa, Y., Sugiura, K., Muro, Y., Abe, R., Suzuki, T., Akiyama, M.

    Journal of the American Academy of Dermatology   Vol. 70 ( 2 )   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jaad.2013.10.055

    Scopus

  26. Establishment of an ELISA to detect anti-glycyl-tRNA synthetase antibody (anti-EJ), a serological marker of dermatomyositis/polymyositis and interstitial lung disease Reviewed

    Hane, H., Muro, Y., Watanabe, K., Ogawa, Y., Sugiura, K., Akiyama, M.

    Clinica Chimica Acta   Vol. 431   2014

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.cca.2014.01.005

    Scopus

  27. Novel ABCA12 missense mutation p.Phe2144Ser underlies congenital ichthyosiform erythroderma Reviewed

    Shimizu, Y., Sugiura, K., Aoyama, Y., Ogawa, Y., Hitomi, K., Iwatsuki, K., Akiyama, M.

    Journal of Dermatology   Vol. 40 ( 7 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/1346-8138.12169

    Scopus

  28. The majority of generalized pustular psoriasis without psoriasis vulgaris Is caused by deficiency of interleukin-36 receptor antagonist Reviewed International journal

    Sugiura, K., Takemoto, A., Yamaguchi, M., Takahashi, H., Shoda, Y., Mitsuma, T., Tsuda, K., Nishida, E., Togawa, Y., Nakajima, K., Sakakibara, A., Kawachi, S., Shimizu, M., Ito, Y., Takeichi, T., Kono, M., Ogawa, Y., Muro, Y., Ishida-Yamamoto, A., Sano, S., Matsue, H., Morita, A., Mizutani, H., Iizuka, H., Muto, M., Akiyama, M.

    Journal of Investigative Dermatology   Vol. 133 ( 11 ) page: 2514 - 2521   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Generalized pustular psoriasis (GPP) is a rare inflammatory skin disease that can be life-threatening. Recently, it has been reported that familial GPP is caused by homozygous or compound heterozygous mutations of IL36RN. However, the majority of GPP cases are sporadic and it is controversial whether IL36RN mutations are a causative/predisposing factor for sporadic GPP. We searched for IL36RN mutations in two groups of GPP patients in the Japanese population in this study: GPP without psoriasis vulgaris (PV), and GPP with PV. Eleven cases of GPP without PV (GPP alone) and 20 cases of GPP accompanied by PV (GPP with PV) were analyzed. Surprisingly, 9 out of 11 cases of GPP alone had homozygous or compound heterozygous mutations in IL36RN. In contrast, only 2 of 20 cases of GPP with PV had compound heterozygous mutations in IL36RN. The two cases of GPP with PV who had compound heterozygous mutations in IL36RN are siblings, and both cases had PV-susceptible HLA-A*0206. We determined that GPP alone is a distinct subtype of GPP and is etiologically distinguished from GPP with PV, and that the majority of GPP alone is caused by deficiency of the interleukin-36 receptor antagonist due to IL36RN mutations.

    DOI: 10.1038/jid.2013.230

    Scopus

    PubMed

  29. Possible roles of barrier-to-autointegration factor 1 in regulation of keratinocyte differentiation and proliferation Reviewed

    Takama, H., Sugiura, K., Ogawa, Y., Muro, Y., Akiyama, M.

    Journal of Dermatological Science   Vol. 71 ( 2 )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jdermsci.2013.04.007

    Scopus

  30. Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 30-repair exonuclease 1 Reviewed

    Sugiura, K., Takeichi, T., Kono, M., Ito, Y., Ogawa, Y., Muro, Y., Akiyama, M.

    Journal of Investigative Dermatology   Vol. 132 ( 12 ) page: 2855-7   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jid.2012.210

    Scopus

  31. A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis Reviewed

    Sugiura, K., Takeichi, T., Kono, M., Ogawa, Y., Shimoyama, Y., Muro, Y., Akiyama, M.

    British Journal of Dermatology   Vol. 167 ( 3 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1365-2133.2012.10953.x

    Scopus

  32. Challenges to congenital genetic disorders with "RNA-targeting" chemical compounds Reviewed

    Ogawa, Y., Hagiwara, M.

    Pharmacology and Therapeutics   Vol. 134 ( 3 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pharmthera.2012.02.001

    Scopus

  33. LEDGF/DFS70 activates the MK2/IL6/STAT3 pathway in HaCaT Reviewed

    Takeichi, T., Sugiura, K., Muro, Y., Ogawa, Y., Akiyama, M.

    Journal of Dermatological Science   Vol. 63 ( 3 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jdermsci.2011.05.004

    Scopus

  34. Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: Modulation of alternative pre-RNA splicing Reviewed

    Debdab, M., Carreaux, F., Renault, S., Soundararajan, M., Fedorov, O., Filippakopoulos, P., Lozach, O., Babault, L., Tahtouh, T., Baratte, B., Ogawa, Y., Hagiwara, M., Eisenreich, A., Rauch, U., Knapp, S., Meijer, L., Bazureau, J.-P.

    Journal of Medicinal Chemistry   Vol. 54 ( 12 )   2011

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1021/jm200274d

    Scopus

  35. Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A Reviewed

    Ogawa, Y., Nonaka, Y., Goto, T., Ohnishi, E., Hiramatsu, T., Kii, I., Yoshida, M., Ikura, T., Onogi, H., Shibuya, H., Hosoya, T., Ito, N., Hagiwara, M.

    Nature Communications   Vol. 1 ( 7 )   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome. The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery. Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC50 and K-i values of 0.24 and 0.18 mu M, respectively. X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme. INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression. Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.

    DOI: 10.1038/ncomms1090

    Web of Science

    Scopus

  36. Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition Reviewed

    Takeichi, T., Sugiura, K., Muro, Y., Matsumoto, K., Ogawa, Y., Futamura, K., Kaminuma, O., Hashimoto, N., Shimoyama, Y., Saito, H., Tomita, Y.

    Journal of Investigative Dermatology   Vol. 130 ( 12 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jid.2010.203

    Scopus

  37. Intravital imaging of IL-1Β production in skin Reviewed

    Matsushima, H., Ogawa, Y., Miyazaki, T., Tanaka, H., Nishibu, A., Takashima, A.

    Journal of Investigative Dermatology   Vol. 130 ( 6 )   2010

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/jid.2010.11

    Scopus

  38. Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members Reviewed

    Goetz, R., Beenken, A., Ibrahimi, O.A., Kalinina, J., Olsen, S.K., Eliseenkova, A.V., Xu, C., Neubert, T.A., Zhang, F., Linhardt, R.J., Yu, X., White, K.E., Inagaki, T., Kliewer, S.A., Yamamoto, M., Kurosu, H., Ogawa, Y., Kuro-o, M., Lanske, B., Razzaque, M.S., Mohammadi, M.

    Molecular and Cellular Biology   Vol. 27 ( 9 )   2007

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1128/MCB.02249-06

    Scopus

  39. βKlotho is required for metabolic activity of fibroblast growth factor 21 Reviewed

    Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K.P., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Kuro-O, M.

    Proceedings of the National Academy of Sciences of the United States of America   Vol. 104 ( 18 )   2007

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1073/pnas.0701600104

    Scopus

  40. Tissue-specific expression of βklotho and Fibroblast Growth Factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 Reviewed

    Kurosu, H., Choi, M., Ogawa, Y., Dickson, A.S., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Rosenblatt, K.P., Kliewer, S.A., Kuro-O, M.

    Journal of Biological Chemistry   Vol. 282 ( 37 )   2007

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1074/jbc.M704165200

    Scopus

  41. Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodies Reviewed

    Goto, N., Sugiura, K., Ogawa, Y., Watanabe, A., Onouchi, H., Tomita, Y., Muro, Y.

    Journal of Autoimmunity   Vol. 26 ( 1 )   2006

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jaut.2005.09.001

    Scopus

  42. Regulation of fibroblast growth factor-23 signaling by Klotho Reviewed

    Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K.P., Baum, M.G., Schiavi, S., Hu, M.-C., Moe, O.W., Kuro-o, M.

    Journal of Biological Chemistry   Vol. 281 ( 10 )   2006

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1074/jbc.C500457200

    Scopus

  43. Identification of novel pharmacological activities of an antifungal agent, nystatin, to promote dendritic cell maturation Reviewed

    Ogawa, Y., Mizumoto, N., Tanaka, H., Matsushima, H., Takashima, A.

    Journal of Investigative Dermatology   Vol. 126 ( 2 )   2006

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/sj.jid.5700081

    Scopus

  44. HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease Reviewed

    Muro, Y., Ogawa, Y., Sugiura, K., Tomita, Y.

    Journal of Autoimmunity   Vol. 26 ( 4 )   2006

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jaut.2006.03.005

    Scopus

  45. Discovery of novel immunostimulants by dendritic-cell-based functional screening Reviewed

    Mizumoto, N., Gao, J., Matsushima, H., Ogawa, Y., Tanaka, H., Takashima, A.

    Blood   Vol. 106 ( 9 )   2005

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1182/blood-2005-03-1161

    Scopus

  46. Regulation of oxidative stress by the anti-aging hormone klotho Reviewed

    Yamamoto, M., Clark, J.D., Pastor, J.V., Gurnani, P., Nandi, A., Kurosu, H., Miyoshi, M., Ogawa, Y., Castrillon, D.H., Rosenblatt, K.P., Kuro-O, M.

    Journal of Biological Chemistry   Vol. 280 ( 45 )   2005

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1074/jbc.M509039200

    Scopus

  47. A case of refractory bullous pemphigoid with plasmapheresis-associated thrombopenia: Efficacy of pulsed intravenous cyclophosphamide therapy Reviewed

    Ogawa, Y., Adachi, A., Okamoto, M., Hashimoto, T., Tomita, Y.

    Journal of Dermatology   Vol. 31 ( 8 )   2004

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1346-8138.2004.tb00571.x

    Scopus

  48. Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain Reviewed

    Ogawa, Y., Sugiura, K., Watanabe, A., Kunimatsu, M., Mishima, M., Tomita, Y., Muro, Y.

    Journal of Autoimmunity   Vol. 23 ( 3 )   2004

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jaut.2004.07.003

    Scopus

  49. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients Reviewed International journal

    Okamoto, M., Ogawa, Y., Watanabe, A., Sugiura, K., Shimomura, Y., Aoki, N., Nagasaka, T., Tomita, Y., Muro, Y.

    Journal of Autoimmunity   Vol. 23 ( 3 ) page: 257 - 66   2004

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Alopecia areata (AA) has been suspected to be an autoimmune disease, although there is no distinct evidence, we investigated the relationship between AA and autoantibodies against dense fine speckles 70 kDa (DFS70) in 111 patients with alopecia and 105 healthy controls. The sera from 59 out of 111 (53%) Japanese alopecia patients were positive for anti-nuclear antibody (ANA), as compared to the sera of 16 out of 105 (15%) healthy controls (p < 0.001). Twenty percent (22/111) of the alopecia patients were shown to be positive for the prevalence of anti-DFS70 antibodies, as compared to 8% (8/105) of the healthy controls (p < 0.01). IgG subclass analysis by ELISA showed that IgG1 and IgG2-anti-DFS70 antibodies were dominant in alopecia patients. The DFS70 gene expression in the hair structures was clearly detected in both those with and those without the anti-DFS70 antibody by RT-PCR. Immunohistochemical techniques showed that the DFS70 was localized predominantly in the outer root sheath (ORS) cells. The elevated anti-DFS70 antibodies in alopecia patients and the localization of the DFS70 in the ORS suggest that autoantibodies against the DFS70 are related to the etiology in a certain population of AA.

    DOI: 10.1016/j.jaut.2004.07.004

    Scopus

    PubMed

  50. The Successful Use of Topical Tacrolimus Treatment for a Chronic Actinic Dermatitis Patient with Complications of Idiopathic Leukopenia Reviewed

    Ogawa, Y., Adachi, A., Tomita, Y.

    Journal of Dermatology   Vol. 30 ( 11 )   2003

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/j.1346-8138.2003.tb00482.x

    Scopus

  51. Autoantibody to thioredoxin reductase in an ovarian cancer patient Reviewed

    Muro, Y., Ogawa, Y., Kato, Y., Hagiwara, M.

    Biochemical and Biophysical Research Communications   Vol. 242 ( 2 )   1998

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1006/bbrc.1997.7914

    Scopus

  52. Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein Reviewed

    Shimomura, A., Ogawa, Y., Kitani, T., Fujisawa, H., Hagiwara, M.

    Journal of Biological Chemistry   Vol. 271 ( 30 )   1996

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1074/jbc.271.30.17957

    Scopus

▼display all

MISC 11

  1. 抗PM/Scl抗体陽性皮膚筋炎の3例はじめに

    桃原 真理子, 室 慶直, 滝 奉樹, 小川 靖, 杉浦 一充, 秋山 真志, 岡地 祥太郎, 曽根 淳

    中部リウマチ   Vol. 46 ( 2 ) page: 37 - 37   2017.3

     More details

    Language:Japanese   Publisher:中部リウマチ学会  

  2. ヒト表皮ケラチノサイトにおけるABCA12プロモーターの解析 プロモーター活性に必要なパリンドローム配列の同定

    小川 靖, 清水 由隆, 杉浦 一充, 秋山 真志, 武田 淳一, 澤田 香織, 柳 輝希, 清水 宏, 今 淳, 澤村 大輔

    角化症研究会記録集   Vol. 30   page: 18 - 21   2016.3

     More details

    Language:Japanese   Publisher:角化症研究会事務局  

  3. 片側優位性に症状を呈した点状掌蹠角化症の1例

    滝 奉樹, 小川 靖, 秋山 真志, 榊原 彰浩

    日本皮膚科学会雑誌   Vol. 126 ( 2 ) page: 195 - 195   2016.2

     More details

    Language:Japanese   Publisher:(公社)日本皮膚科学会  

  4. TREX1新規変異p.Pro132Alaによる家族性凍瘡状狼瘡の1例

    杉浦 一充, 武市 拓也, 河野 通浩, 小川 靖, 室 慶直, 秋山 真志

    中部リウマチ   Vol. 44 ( 1 ) page: 58 - 58   2014.7

     More details

    Language:Japanese   Publisher:中部リウマチ学会  

  5. 尋常性乾癬を伴わない汎発性膿疱性乾癬の大半はIL-36RN欠損症(DITRA)である

    杉浦 一充, 武市 拓也, 河野 通浩, 小川 靖, 室 慶直, 秋山 真志, 武藤 正彦

    日本皮膚科学会雑誌   Vol. 124 ( 5 ) page: 979 - 979   2014.4

     More details

    Language:Japanese   Publisher:(公社)日本皮膚科学会  

  6. 尋常性乾癬を伴わない汎発性膿疱性乾癬の大半はIL-36RN欠損症(DITRA)である

    杉浦 一充, 武市 拓也, 河野 通浩, 小川 靖, 室 慶直, 秋山 真志, 武藤 正彦

    日本皮膚科学会雑誌   Vol. 124 ( 2 ) page: 201 - 201   2014.2

     More details

    Language:Japanese   Publisher:(公社)日本皮膚科学会  

  7. 尋常性乾癬を伴わない汎発性膿疱性乾癬の大半はIL-36RN欠損症(DITRA)である

    杉浦 一充, 武市 拓也, 河野 通浩, 小川 靖, 室 慶直, 武藤 正彦, 秋山 真志

    Journal of Environmental Dermatology and Cutaneous Allergology   Vol. 7 ( 5 ) page: 475 - 475   2013.11

     More details

    Language:Japanese   Publisher:(一社)日本皮膚アレルギー・接触皮膚炎学会  

  8. TREX1新規変異p.Pro132Alaによる家族性凍瘡状狼瘡の1例

    杉浦 一充, 河野 通浩, 小川 靖, 室 慶直, 秋山 真志, 武市 拓也

    日本皮膚科学会雑誌   Vol. 123 ( 4 ) page: 481 - 481   2013.4

     More details

    Language:Japanese   Publisher:(公社)日本皮膚科学会  

  9. IL36RN新規変異p.Arg10Xによる家族性汎発性膿疱性乾癬の成人発症例

    杉浦 一充, 河野 通浩, 小川 靖, 室 慶直, 秋山 真志, 武市 拓也

    日本皮膚科学会雑誌   Vol. 123 ( 4 ) page: 461 - 461   2013.4

     More details

    Language:Japanese   Publisher:(公社)日本皮膚科学会  

  10. LEDGF/DFS70の過剰発現はHaCaT細胞においてp38の活性化を介してIL-6を誘導する 新規乾癬ケラチノサイトモデル

    武市 拓也, 杉浦 一充, 室 慶直, 小川 靖, 二村 恭子, 富田 靖

    角化症研究会記録集   Vol. 25   page: 16 - 20   2011.3

     More details

    Language:Japanese   Publisher:角化症研究会事務局  

  11. Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, which resembles psoriasis

    Takuya Takeichi, Kazumitsu Sugiura, Yoshinao Muro, Kenji Matsumoto, Yasushi Ogawa, Kyoko Futamura, Yasushi Tomita

    JOURNAL OF INVESTIGATIVE DERMATOLOGY   Vol. 130   page: S85 - S85   2010.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:NATURE PUBLISHING GROUP  

    Web of Science

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 9

  1. A proof of concept study of medium chain trygryceride diet based treatment for congenital ichtgyosis

    Grant number:17K10206  2017.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

  2. Elucidation of roles of lipid mediators in the epidermis to innovate novel therapeutic strategies for keratinization disorders

    Grant number:15H04887  2015.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    AKIYAMA Masashi, ISHIKAWA Junko

      More details

    Authorship:Coinvestigator(s) 

    In the present study, we accumulated families with inherited keratinization disorders including ichthyosis, and performed whole exome and/or whole genome sequencing using next generation sequencers to clarify genetic causes of the patients. Clinical information and data from the genetic analysis were collected as our data bank of patients with inherited keratinization disorders.
    To elucidate the interaction between epidermal lipid synthesis and metabolism, and differentiation and proliferation of the epidermal keratinocytes, we analyzed detailed epidermal lipid profiles and differentiation/proliferation statuses of the keratinocytes in our mouse models of inherited ichthyoses. We comprehensively summarized the effects of epidermal functional lipids on differentiation and proliferation of the epidermal keratinocytes. From the present results, we considered novel therapeutic manners for keratinization disorders using epidermal functional lipids and lipid mediators.

  3. Dynamic epigenetic change of keratinocytes in inflammtory skin diseases

    Grant number:26461657  2014.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Yasushi Ogawa, AKIYAMA Masashi

      More details

    Authorship:Principal investigator 

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    This study aimed to investigate the roles of epigenetic changes of keratinocytes in the formation of inflammatory skin lesion of psoriasis. A reverse chemical genomics-approach was adopted. Topical imiquimod-induced skin inflammation was used as a mouse model of psoriasis, and various chemical inhibitors of chromatin modifying enzymes are applied to investigate their effect on the formation of the skin lesion. As a result we newly identified a histone demethylase inhibitor that promote the formation of the lesion, and a kinase inhibitor that suppress the skin lesion.

  4. The disturbed feed forward transcriptional regulation mechanism coupled with disturbed intracellular lipid metabolism in keratinocytes of congenital ichthyosis model mice

    Grant number:25670502  2013.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    OGAWA Yasushi, SUGIURA Kazumitsu, AKIYAMA Masashi

      More details

    Authorship:Principal investigator 

    Grant amount:\3770000 ( Direct Cost: \2900000 、 Indirect Cost:\870000 )

    This study was designed to verify the hypothesized feed forward mechanism of lipid metabolism-transcriptional regulation in differentiating keratinocytes, and find possible application of this putative mechanism in the treatment of congenital skin diseases. For this purpose we utilized Abca12-deficient as a mouse model of harlequin ichthyosis and CGI-58-deficient mouse as a model of neutral lipid storage disease with ichthyosis. Primary keratinocytes taken from the skin of model mice were treated with agonists of PPAR family nuclear receptors. A PPARγagonist restored the decreased expression of a keratinocyte differentiation marker. It could not, however, provide an overall reversal of the disease phenotype. An attempt to inject of PPAR agonist in utero failed to rescue the early death of newborn mice. Search for skin-specific triglyceride lipase was performed using siRNA targeted at PNPLA family members suggested the putative lipase exists otherwise.

  5. Impact of phosphate toxicity on skin aging

    Grant number:24659527  2012.4 - 2013.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    OGAWA Yasushi

      More details

    Authorship:Principal investigator 

    Grant amount:\3770000 ( Direct Cost: \2900000 、 Indirect Cost:\870000 )

    Hyperphosphatemia is caused by several diseases including chronic renal failure, and is often accompanied by skin manifestations that mimic aging. The "phosphate toxicity" hypothesis suggests that hyperphosphatemia induce aging like symptoms of the body, however, the direct consequence of the high phosphate condition on keratinocytes was not well studied.
    In this study we verified that normal human epidermal keratinocytes (NHEK) are driven into early cellular senescence if cultured under non-optimum phosphate condition. NHEK showed highest population doubling levels (PDL) when cultured in 4 mM phosphate and the concentration lower or higher than this level resulted in decreased PDL. The decrease in PDL was accompanied by increased expression of keratinocyte differentiation markers. No increase in senescence associated secreted proteins was observed. It may be suggested that high phosphate condition may drive NHEK to differentiated state leading to accelerated aging-like phenotype.

  6. Elucidation of epigenetic dysregulation of psoriasis lesions and development of novel therapeutic strategy

    Grant number:23689054  2011.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Young Scientists (A)

    OGAWA Yasushi, SUGIURA Kazumitsu, AKIYAMA Masashi

      More details

    Authorship:Principal investigator 

    Grant amount:\25090000 ( Direct Cost: \19300000 、 Indirect Cost:\5790000 )

    The present study examined a novel pathogenic mechanism of psoriasis where the epigenetic changes in affected keratinocytes promotes and stabilize the psoriatic skin lesions. The transcription activation cofactor LEDGF shows unique nuclear localization in the proliferating psoriatic keratinocytes. Our study revealed LEDGF shows extranuclear localization in G0/G1 keratinocyte cells, whereas upon stimulation with extracellular growth signals, it translocalizes to the nucleus via MEK and PI3K kinase-mediated mechanism. LEDGF was found to be a H3K36me3 reader, and when localized to the nucleus, it binds to the H3K36me3 motif and recruits the histone modification complex MLL. The present study is in support of the epigenetic model of psoriasis pathogenesis where the nuclear translocalized LEDGF enhances the di- and tri- methylation of H3K4 of the promoter regions of inflammatory cytokines and other psoriasis associated genes, leading to their enhanced and sustained expression.

  7. Investigation of two-step theory involved with TIF1-gamma in cancer-associated with dermatomyositis

    Grant number:23591618  2011.4 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    MURO YOSHINAO, SUGIURA Kazumitsu, OGAWA Yasushi

      More details

    Authorship:Coinvestigator(s) 

    The pathogenic mechanisms has been still unknown in cancer-associated dermatomyositis (CADM). We investigated whether malignant tissues in CADM have the aberrant expression of TIF1-γ, which is a serological marker of CADM, and also investigated the possibility of interaction between TIF1-γ, and TGFβand other associated molecules. We showed the high expression of TIF1-γ
    in malignant tissues in patients with anti-TIF1-γ and suggested the possibility of tumor growth by the phosphorylation of STAT3 through IL-6.

  8. Innovation of novel treatments for various phenotypes of ichthyosis by restoration of ABCA12 lipid transporter gene expression

    Grant number:23249058  2011.4 - 2014.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (A)

    AKIYAMA Masashi, OGAWA Yasushi, KONO Michihiro, ABE Riichiro, SUGIURA Kazumitsu, MURO Yoshinao

      More details

    Authorship:Coinvestigator(s) 

    In the present study, we established ABCA12-mutant mice harboring ABCA12 partial loss-of-function mutations, as model mice for congenital ichthyosiform erythroderma. In the model mice, we evaluated the up-regulation effects on ABCA12 gene expression by various compounds, which were expected to have up-regulation effects on ABCA12 gene expression. As for the compounds which were proved to have up-regulation effects on ABCA12 gene expression, we further investigated treatment efficacy of the up-regulators of ABCA12 gene expression in the model mice, by monitoring ichthyosis phenotype recovery and restoration of skin barrier function.
    In addition, we also established model mice carrying ABCA12 loss-of-function mutations as a model of harlequin ichthyosis. Using the model mice, we evaluated treatment efficacy of various read-through compounds to harlequin ichthyosis phenotypes by monitoring restoration of the stratum corneum barrier function and phenotype recovery.

  9. Molecular Mechanism of Chemotherapy Resistance of Malignant Melanoma

    Grant number:23659548  2011 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Challenging Exploratory Research

    OGAWA Yasushi

      More details

    Authorship:Principal investigator 

    Grant amount:\3900000 ( Direct Cost: \3000000 、 Indirect Cost:\900000 )

▼display all

Industrial property rights 2

  1. DYRKを阻害するベンゾチアゾール誘導体を含有する医薬組成物

     More details

    Applicant:萩原 正敏、 澁谷 浩司、 大西 英理子、 小川 靖、細谷 孝充、 平松 俊行、 吉田 実代

    Application no:2008-190277  Date applied:2008.7

    Country of applicant:Domestic  

  2. FGF21 Upregulates Expression of GLUT-1 in a βKlotho-Dependent Manner.

     More details

    Applicant:Kuro-o M, Ogawa Y, Kurosu H, Rosenblatt K

    Application no:U.S. Patent Number: 7,537,903 

    Date registered:2009.5 

    Country of applicant:Foreign country